Munich - Delayed Quote EUR

Integra Lifesciences Holdings Corp (IL3.MU)

14.60

+0.50

+(3.55%)

At close: April 25 at 8:04:34 AM GMT+2

3 Hated Stocks Walking a Fine Line

The past year hasn't been kind to the stocks featured in this article. Each has tumbled to their lowest points in 12 months, leaving investors to decide whether they're witnessing fire sales or falling knives.

StockStory 21 hours ago

AMC

IART

SEM
Integra LifeSciences to Host First Quarter 2025 Financial Results Conference Call on May 5, 2025

PRINCETON, N.J., April 18, 2025 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (NASDAQ: IART), a leading global medical technology company, will release first quarter 2025 financial results on Monday, May 5, 2025, prior to the market open. In conjunction with the earnings release, Integra’s management team will host a conference call at 8:30 a.m. ET. A live webcast will be available on the Investors section of the Company’s website at investor.integralife.com. For those planning t

GlobeNewswire 7 days ago

IART
Q4 Earnings Highlights: LeMaitre (NASDAQ:LMAT) Vs The Rest Of The Surgical Equipment & Consumables - Specialty Stocks

Quarterly earnings results are a good time to check in on a company’s progress, especially compared to its peers in the same sector. Today we are looking at LeMaitre (NASDAQ:LMAT) and the best and worst performers in the surgical equipment & consumables - specialty industry.

StockStory 9 days ago

LMAT

ISRG

IART
Spotting Winners: Teleflex (NYSE:TFX) And Surgical Equipment & Consumables - Specialty Stocks In Q4

The end of the earnings season is always a good time to take a step back and see who shined (and who not so much). Let’s take a look at how surgical equipment & consumables - specialty stocks fared in Q4, starting with Teleflex (NYSE:TFX).

StockStory 11 days ago

TFX

ISRG

IART
Do Options Traders Know Something About Integra (IART) Stock We Don't?

Investors need to pay close attention to Integra (IART) stock based on the movements in the options market lately.

Zacks 16 days ago

IART
Argus upgrades Integra to Buy, says well-positioned for a turnaround

Argus analyst David Toung upgraded Integra LifeSciences (IART) to Buy from Hold with a $28 price target The firm sees the company as well-positioned for a turnaround, and with supply issues for Integra Skin products resolved, the company now expects sequentially stronger top and bottom-line growth as 2025 progresses. Argus also expects that under the leadership of new CEO Mojdeh Poul, the company will improve operations and sales execution in order tot meet demand for its reconstructive and neur

TipRanks 24 days ago

IART
Integra (IART) Down 7.5% Since Last Earnings Report: Can It Rebound?

Integra (IART) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

Zacks 29 days ago

IART
Winners And Losers Of Q4: Integra LifeSciences (NASDAQ:IART) Vs The Rest Of The Surgical Equipment & Consumables - Specialty Stocks

Looking back on surgical equipment & consumables - specialty stocks’ Q4 earnings, we examine this quarter’s best and worst performers, including Integra LifeSciences (NASDAQ:IART) and its peers.

StockStory 30 days ago

IART

ISRG

TFX
Is This the Right Time to Hold Integra Stock in Your Portfolio?

IART stays on investors' radar courtesy of its strong prospects in the CSS segment and international growth.

Zacks 30 days ago

IART

BSX
Q4 Earnings Review: Surgical Equipment & Consumables - Specialty Stocks Led by Intuitive Surgical (NASDAQ:ISRG)

As the Q4 earnings season comes to a close, it’s time to take stock of this quarter’s best and worst performers in the surgical equipment & consumables - specialty industry, including Intuitive Surgical (NASDAQ:ISRG) and its peers.

StockStory last month

ISRG

LMAT

TFX
3 Value Stocks in the Doghouse

The low valuation multiples for value stocks provide a margin of safety that growth stocks rarely offer. However, the challenge lies in determining whether these cheap assets are genuinely undervalued or simply on sale due to their potentially deteriorating business models.

StockStory last month

SSTK

IART
3 Reasons IART is Risky and 1 Stock to Buy Instead

While the broader market has struggled with the S&P 500 down 1.3% since September 2024, Integra LifeSciences has surged ahead as its stock price has climbed by 31.6% to $22.79 per share. This performance may have investors wondering how to approach the situation.

StockStory last month

IART
Integra LifeSciences to Present at the Oppenheimer 35th Annual Healthcare MedTech & Services Conference

PRINCETON, N.J., March 13, 2025 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (NASDAQ: IART), a leading global medical technology company, announced today that Mojdeh Poul, chief executive officer and Lea Knight, chief financial officer will present at the 35th Annual Oppenheimer Healthcare MedTech & Services Conference on March 17, 2025 at 10:00am ET. A live webcast of the presentation will be available on the Integra LifeSciences investor relations website at https://investor.i

GlobeNewswire last month

IART
3 Small-Cap Stocks in the Doghouse

Small-cap stocks can be incredibly lucrative investments because their lack of analyst coverage leads to frequent mispricings. However, these businesses (and their stock prices) often stay small because their subscale operations make it harder to expand their competitive moats.

StockStory last month

TDOC

IART

PRPL
Integra Q4 Earnings Beat Estimates, Revenues Rise Y/Y, Stock Up

IART delivers better-than-expected earnings in the fourth quarter of 2024.

Zacks last month

IART

RMD

CAH
Integra Lifesciences Holdings Corp (IART) Q4 2024 Earnings Call Highlights: Strong Revenue ...

Despite a robust 11.5% revenue increase, Integra Lifesciences Holdings Corp (IART) faces ongoing supply chain and quality hurdles impacting future growth.

GuruFocus.com last month

IART
Q4 2024 Integra Lifesciences Holdings Corp Earnings Call

Q4 2024 Integra Lifesciences Holdings Corp Earnings Call

Thomson Reuters StreetEvents last month

IART
Why Is Integra LifeSciences (IART) Stock Rocketing Higher Today

Shares of medical device company Integra LifeSciences (NASDAQ:IART) jumped 13.6% in the afternoon session after the company reported strong fourth quarter 2024 results that beat analysts' EPS and EBITDA expectations.

StockStory last month

IART
Integra (IART) Reports Q4 Earnings: What Key Metrics Have to Say

Although the revenue and EPS for Integra (IART) give a sense of how its business performed in the quarter ended December 2024, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.

Zacks last month

IART
Integra LifeSciences (IART) Surpasses Q4 Earnings Estimates

Integra (IART) delivered earnings and revenue surprises of 14.12% and 0.45%, respectively, for the quarter ended December 2024. Do the numbers hold clues to what lies ahead for the stock?

Zacks last month

IART

Performance Overview

Return	IL3.MU	S&P 500 (^GSPC)
YTD	-31.78%	-6.06%
1-Year	-46.72%	+9.44%
3-Year	-75.25%	+28.61%

News

Life

Entertainment

Finance

Sports

New on Yahoo

Yahoo Finance

Integra Lifesciences Holdings Corp (IL3.MU)

3 Hated Stocks Walking a Fine Line

Integra LifeSciences to Host First Quarter 2025 Financial Results Conference Call on May 5, 2025

Q4 Earnings Highlights: LeMaitre (NASDAQ:LMAT) Vs The Rest Of The Surgical Equipment & Consumables - Specialty Stocks

Spotting Winners: Teleflex (NYSE:TFX) And Surgical Equipment & Consumables - Specialty Stocks In Q4

Do Options Traders Know Something About Integra (IART) Stock We Don't?

Argus upgrades Integra to Buy, says well-positioned for a turnaround

Integra (IART) Down 7.5% Since Last Earnings Report: Can It Rebound?

Winners And Losers Of Q4: Integra LifeSciences (NASDAQ:IART) Vs The Rest Of The Surgical Equipment & Consumables - Specialty Stocks

Is This the Right Time to Hold Integra Stock in Your Portfolio?

Q4 Earnings Review: Surgical Equipment & Consumables - Specialty Stocks Led by Intuitive Surgical (NASDAQ:ISRG)

3 Value Stocks in the Doghouse

3 Reasons IART is Risky and 1 Stock to Buy Instead

Integra LifeSciences to Present at the Oppenheimer 35th Annual Healthcare MedTech & Services Conference

3 Small-Cap Stocks in the Doghouse

Integra Q4 Earnings Beat Estimates, Revenues Rise Y/Y, Stock Up

Integra Lifesciences Holdings Corp (IART) Q4 2024 Earnings Call Highlights: Strong Revenue ...

Q4 2024 Integra Lifesciences Holdings Corp Earnings Call

Why Is Integra LifeSciences (IART) Stock Rocketing Higher Today

Integra (IART) Reports Q4 Earnings: What Key Metrics Have to Say

Integra LifeSciences (IART) Surpasses Q4 Earnings Estimates

Performance Overview